Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Ronald N. Marcus, MD
JCP
Original Research
Aripiprazole Effects in Patients With Acute Schizophrenia Experiencing Higher or Lower Agitation: A Post Hoc Analysis of 4 Randomized, Placebo-Controlled Clinical Trials
May 15, 2007
Stephen R. Marder
,
Britt West
,
Gina S. Lau
, et al
JCP
Original Research
Aripiprazole for Treatment-Resistant Schizophrenia: Results of a Multicenter, Randomized, Double-Blind, Comparison Study Versus Perphenazine
February 15, 2007
John M. Kane
,
Herbert Y. Meltzer
,
William H. Carson, Jr.
, et al
JCP
Original Research
Efficacy and Safety of Intramuscular Aripiprazole in Patients With Acute Agitation: A Randomized, Double-Blind, Placebo-Controlled Trial
January 15, 2007
Tram K. Tran-Johnson
,
David A. Sack
,
Ronald N. Marcus
, et al
JCP
Original Research
A Randomized, Double-Blind, Placebo-Controlled 26-Week Trial of Aripiprazole in Recently Manic Patients With Bipolar I Disorder.
April 15, 2006
Joseph R. Calabrese
,
Robert D. McQuade
,
William H. Carson
, et al
«
1
2
